Related Experiment Video
Updated: Oct 30, 2025
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
111
Pediatric Hodgkin Lymphoma, Version 3.2021.
Jamie E Flerlage1, Susan M Hiniker2, Saro Armenian3
11St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
Summary
Pediatric Hodgkin lymphoma (HL) treatment guidelines focus on enhancing cure rates and minimizing long-term side effects. These NCCN Guidelines cover diagnosis, staging, and therapy for upfront and relapsed cases.
Area of Science:
- Oncology
- Pediatric Hematology/Oncology
Background:
- Hodgkin lymphoma (HL) is a curable malignancy in children.
- Current treatments aim to improve efficacy and reduce late effects.
- Pediatric HL management requires specialized guidelines.
Purpose of the Study:
- To present the NCCN Clinical Practice Guidelines for pediatric classic Hodgkin lymphoma.
- To provide recommendations for the workup, diagnosis, and treatment of pediatric HL.
- To address both upfront and relapsed/refractory settings.
Main Methods:
- The NCCN Guidelines synthesize current evidence and expert consensus.
- Recommendations cover pathology, imaging, staging, systemic therapy, and radiation therapy.
- Focus on management principles for pediatric classic HL.
Main Results:
- Detailed recommendations for the diagnostic evaluation of pediatric HL.
- Guidance on systemic therapy and radiation therapy approaches.
- Strategies for managing upfront and relapsed/refractory pediatric HL.
Conclusions:
- The NCCN Guidelines offer a comprehensive framework for pediatric HL management.
- Emphasis on optimizing treatment to improve cure and reduce long-term toxicity.
- Standardized approach to pediatric classic HL care is essential.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
64
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
64
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
48
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
48
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
50
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
48
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
01:16Primary Lymphoid Organs
12.3K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
12.3K